Therefore, abnormalities of lipoprotein metabolism may explain, at least in part, the associations between APOE ε2/ε3/ε4 polymorphisms and the risk of CAD in patients with T2DM. This evidence concerns the gene APOE and type 2 diabetes mellitus.